Navigation Links
Goodwin Biotechnology Inc. and Macrocyclics Announce Collaboration
Date:2/10/2010

PLANTATION, Fla. and DALLAS, Feb. 10 /PRNewswire/ -- Goodwin Biotechnology Inc., a full service Contract Biomanufacturing Company and Macrocyclics, Inc., a manufacturer of customized chelating agents, jointly announced today their collaborative agreement on Chelation and Bioconjugation.  The collaboration will strengthen joint customer projects in Nuclear Medicine involving Chelation, Bioconjugation and GMP manufacturing.

"Clinical development programs in nuclear medicine with biotargeted agents require combining chelation chemistry and bioconjugation chemistry to create a product," said Garry E. Kiefer, Ph.D., Chief Executive Officer at Macrocyclics.   "In Goodwin Bio, we found a perfect collaborator to jointly advance diagnostic and therapeutic medicine."

"We are excited about collaborating with Macrocyclics, a company dedicated to the leading-edge development of new chelation chemistry platforms," said Muctarr Sesay, Ph.D., Vice President of Process Development at Goodwin Bio.  "Our integrated cGMP services combined with Macrocyclics' chelation expertise will enhance clinical development programs in nuclear medicine."

About Goodwin Biotechnology, Inc.

Goodwin Bio, (GBI) located in Plantation, FL., is a full service contract biomanufacturing company and specializes in process development and cGMP production of protein based therapeutics for pre-clinical and early phase clinical trials. The products manufactured by Goodwin Bio are being used in clinical trials and the Company has assisted in the preparation of several IND filings for various clients.  GBI caters small to midsize biotech companies, universities, cancer research institutes and various branches of the U.S. Government.

About Macrocyclics, Inc:

Macrocyclics, (Macrocyclics, Inc.) located in Dallas, TX., a manufacturer of customized chelating agents, is dedicated to leading-edge development of new chelation chemistry platforms critical for advancement of diagnostic and therapeutic medicine. A broad library of catalog products designed to meet the needs of basic and applied research customers as well as custom cGMP products and services to accelerate clinical development programs are provided.  Clients are international and include government agencies, scientific investigators, biotech and pharmaceutical companies.

SOURCE Goodwin Biotechnology Inc.


'/>"/>
SOURCE Goodwin Biotechnology Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Spherix Shareholders Support Companys Focus on Naturlose, Biotechnology
2. New White Paper Details Strategies for Biotechnology Companies to Improve EH&S Compliance
3. Thomson Scientific to Host Pharmaceutical Vision - A Users Conference for Information, Regulatory Affairs, Competitive Intelligence and Biotechnology Professionals
4. Lixte Biotechnology Holdings, Inc. Announces the Initial Trading of Its Common Stock Under the Symbol: LIXT
5. Luminex Corporation to Present at Biotechnology Industry Organization Investor Forum
6. An Uncommon Eye: Photography Exhibit by Biotechnology Executive at BHCC Gallery
7. Onyx Pharmaceuticals to Present at Biotechnology Industry Organization Investor Forum
8. Leading Biotechnology Company Grows with StayinFront CRM
9. Kosan Biosciences to Present at the Biotechnology Industry Organization Investor Forum
10. Wyeth Pharmaceuticals Acquires Haptogen Ltd. to Boost Biotechnology Drug Discovery
11. Bionovo to Present at the Biotechnology Industry Organization (BIO) Investor Forum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... ... February 09, 2016 , ... With a presidential election in November and the ... will bring together over 500 top healthcare leaders for a night and day of ... organized by MBA students of the University of Pennsylvania’s Wharton School, will be held ...
(Date:2/9/2016)... of Prussia, PA (PRWEB) , ... February 09, 2016 , ... ... Business Development, Europe. Based in Paris, he will focus on acquiring new accounts ... are being met. , “Fred brings to our European clients more ...
(Date:2/9/2016)... 2016 This market research report on the ... prospects of the market in terms of revenue (USD ... in the manufacture of microbiology culture media and related ... market snapshot providing the overall information of various market ... section also provides the overall information and data analysis ...
(Date:2/8/2016)... - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today ... technology companies in the TSX Venture 50 TM . ... the TSX Venture Exchange, in each of five major industry ... & life sciences, diversified industries and technology – based on ... investment, market cap growth, trading volume and analyst coverage. All ...
Breaking Biology Technology:
(Date:2/2/2016)... Feb. 2, 2016  BioMEMS devices deployed ... focused on medical screening and diagnostic applications, ... Wearable devices that facilitate and assure continuous ... movement are being bolstered through new opportunities ... signal acquisition coupled with wireless connectivity and ...
(Date:2/2/2016)... , Feb. 2, 2016 Technology Enhancements Accelerate ... an analysis of the digital and computed radiography markets ... , and Indonesia (TIM). ... and market size, as well as regional market drivers ... and discusses market penetration and market attractiveness, both for ...
(Date:2/1/2016)... Rising sales of consumer electronics ... intuitive gesture control market size ... consumer electronics coupled with new technological advancements to drive ... through 2020   --> ... advancements to drive global touchfree intuitive gesture control market ...
Breaking Biology News(10 mins):